Interleukin-35: The Future of Hyperimmune-Related Diseases?

Journal of Interferon and Cytokine Research

Volumn 33, Issue 6, 2013, Pages 285-291

  Ye, Sunyi ^a   Wu, Jian ^a   Zhou, Lin ^a   Lv, Zhen ^a   Xie, Haiyang ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 35; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC DISEASE; ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELL PROLIFERATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; THERAPY EFFECT;

ANIMALS; HUMANS; IMMUNE SYSTEM DISEASES; INTERLEUKINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

ERAGROSTIS TEF; HUMAN HERPESVIRUS 4;

EID: 84878537521     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0086     Document Type: Review

References (80)

1. Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278(3):1910-1914. (Pubitemid 36801431)
2. Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA. 1995. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: Differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 181(1):399-404.
3. Bai J, Qiu SL, Zhong XN, Huang QP, He ZY, Zhang JQ, Liu GN, Li MH, Deng JM. 2012. Erythromycin enhances CD4 (+) Foxp3 (+) regulatory T-cell responses in a rat model of smokeinduced lung inflammation. Mediators Inflamm 2012:410232.
4. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Herminef A, Devergne O. 2008. Human CD4+ CD25 + Foxp3 + regulatory T cells do not constitutively express IL-35. J Immunol 181(10):6898-6905.
5. Bettini M, Castellaw AH, Lennon GP, Burton AR, Vignali DA. 2012. Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes 61(6):1519-1526.
6. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. 2009. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 76(1):10-14.
7. Bullens D, Ceuppens JL. 2008. Influence of Toll-like-receptor ligands on the dendritic cell-T cell interactions: Therapeutic options for allergic diseases? Mini-review. Inflamm Allergy Drug Targets 7(4):211-216.
8. Castellani ML, Anogeianaki A, Felaco P, Toniato E, De Lutiis MA, Shaik B, Fulcheri M, Vecchiet J, Tete S, Salini V, Theoharides TC, Caraffa A, Antinolfi P, Frydas I, Conti P, Cuccurullo C, Ciampoli C, Cerulli G, Kempuraj D. 2010. IL-35, an anti-inflammatory cytokine which expands CD4+ CD25 +Treg cells. J Biol Regul Homeost Agents 24(2):131-135.
9. Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA. 2011. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 186(12):6661-6666.
10. Chen WJ, Jin W, Hardegen N, Lei K, Li L, Marinos N, McGrady G, Wahl SM. 2003. Conversion of peripheral CD4 + CD25-naive T cells to CD4 + CD25 + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12): 1875-1886. (Pubitemid 38032120)
11. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093-1101.
12. Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather DL, Satoskar AR, Garcia KC, Hunter CA, Drake CG. 2012. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 13(3):290-299.
13. Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-And IL-10-dependent manner. J Immunol 182(10):6121-6128.
14. Collison LW, Vignali DAA. 2008. Interleukin-35: Odd one out or part of the family? Immunol Rev 226(1):248-262.
15. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS, Vignali DAA. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566-569. (Pubitemid 350190247)
16. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744-748. (Pubitemid 36227625)
17. Devergne O, Birkenbach M, Kieff E. 1997. Epstein-Barr virusinduced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A 94(22):12041-12046. (Pubitemid 27467839)
18. Devergne O, Coulomb-L'Hermine A, Capel F, Moussa M, Capron F. 2001. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: Involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 159(5):1763-1776. (Pubitemid 33062519)
19. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M. 1996. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 70(2):1143-1153. (Pubitemid 26029036)
20. Frank GM, Divito SJ, Maker DM, Xu M, Hendricks RL. 2010. A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis. Invest Ophthalmol Vis Sci 51(7):3591-3598.
21. Gollob JA, Murphy EA, Mahajan S, Schnipper CP, Ritz J, Frank DA. 1998. Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood 91(4):1341-1354. (Pubitemid 28086888)
22. Gravano DM, Vignali DA. 2012. The battle against immunopathology: Infectious tolerance mediated by regulatory T cells. Cell Mol Life Sci 69(12):1997-2008.
23. Grazia Roncarolo M, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Reviews 212(1):28-50. (Pubitemid 44116698)
24. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. 1997. A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737-742. (Pubitemid 27458961)
25. Holscher C, Holscher A, Ruckerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174(6):3534-3544. (Pubitemid 40354062)
26. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, Zhang M, Hisaeda H, Mak TW, Yoshimura A. 2003.WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19(5):657-667. (Pubitemid 37490791)
27. Hamza T, Barnett JB, Li B. 2010. Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci 11(3):789-806.
28. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. 2003. IL-27 and IFN-Alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23(9):513-522. (Pubitemid 37130074)
29. Huang CH, Loo EX, Kuo IC, Soh GH, Goh DL, Lee BW, Chua KY. 2011. Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol 187(1): 462-471.
30. Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T. 2004. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol 173(6):3871-3877. (Pubitemid 39280750)
31. Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 25:221-242. (Pubitemid 46697908)
32. Kempe S, Heinz P, Kokai E, Devergne O, Marx N, Wirth T. 2009. Epstein-Barr virus-induced gene-3 is expressed in human atheroma plaques. Am J Pathol 175(1):440-447.
33. Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW. 2010. IL-35 stimulation of CD39 + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 184(12):7144-7153.
34. Langhans B, Braunschweiger I, Arndt S, Schulte W, Satoguina J, Layland LE, Vidovic N, Hoerauf A, Oldenburg J, Sauerbruch T. 2010. Core-specific adaptive regulatory T cells in different outcomes of hepatitis C. Clin Sci 119(2):97-109.
35. Lankford CSR, Frucht DM. 2003. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73(1):49-56. (Pubitemid 36125674)
36. Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, Gutchigian S, Frisch A, Hodge I, Jiang X, Wang H, Yang XF. 2012. IL-35 is a novel responsive anti-inflammatory cytokine - a new system of categorizing anti-inflammatory cytokines. PLoS One 7(3): e33628.
37. Liu JQ, Liu Z, Zhang X, Shi Y, Talebian F, Carl JW, Jr., Yu C, Shi FD, Whitacre CC, Trgovcich J, Bai XF. 2012. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis. J Immunol 188(7): 3099-3106.
38. Lucas S, Ghilardi N, Li J, de Sauvage FJ. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 100(25):15047-15052. (Pubitemid 37518014)
39. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. 1996. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 183(1):147-157. (Pubitemid 26028754)
40. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O'Malley JT, Kapur R, Levy DE, Kansas GS, Kaplan MH. 2007. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178(8):4901-4907. (Pubitemid 46595272)
41. Mikus LD, Rosenthal LA, Sorkness RL, Lemanske RF, Jr. 2001. Reduced interferon-gamma secretion by natural killer cells from rats susceptible to postviral chronic airway dysfunction. Am J Respir Cell Mol Biol 24(1):74-82. (Pubitemid 32097510)
42. Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T. 2006. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25(5):745-755. (Pubitemid 46131400)
43. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198(12):1951-1957. (Pubitemid 38032126)
44. Neufert C, Becker C, Wirtz S, Fantini MC, Weigmann B, Galle PR, Neurath MF. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur J Immunol 37(7):1809-1816. (Pubitemid 47065120)
45. Niedbala W, Wei X, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. 2007. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37(11):3021-3029. (Pubitemid 350131282)
46. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5):715-725.
47. Ozbek N, Fieschi C, Yilmaz BT, de Beaucoudrey L, Demirhan B, Feinberg J, Bikmaz YE, Casanova JL. 2005. Interleukin-12 receptor b1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis 40(6):e55-58.
48. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W, Wagner J, O'Farrell AM, McClanahan T, Zurawski S, Hannum C, Gorman D, Rennick DM, Kastelein RA, de Waal Malefyt R, Moore KW. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168(11):5699-5708. (Pubitemid 34556153)
49. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA. 2004. WSX-1 and glycoprotein 130 constitute a signaltransducing receptor for IL-27. J Immunol 172(4):2225-2231. (Pubitemid 38182370)
50. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16(6):779-790. (Pubitemid 34786477)
51. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A 93(24):14002-14007.
52. Schoenhaut D, Chua A, Wolitzky A, Quinn P, Dwyer C, McComas W, Familletti P, Gately M, Gubler U. 1992. Cloning and expression of murine IL-12. J Immunol 148(11):3433-3440.
53. Seyerl M, Kirchberger S, Majdic O, Seipelt J, Jindra C, Schrauf C, St ckl J. 2010. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol 40(2):321-329.
54. Shevach EM. 2006. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25(2):195-201. (Pubitemid 44224153)
55. Stern AS, Podlaski FJ, Hulmes JD, Pan Y, Quinn PM, Wolitzky A, Familletti PC, Stremlo DL, Truitt T, Chizzonite R. 1990. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human Blymphoblastoid cells. Proc Natl Acad Sci 87(17):6808-6812.
56. Sur S, Bouchard P, Holbert D, Van Scott MR. 2000. Mucosal IL-12 inhibits airway reactivity to methacholine and respiratory failure in murine asthma. Exp Lung Res 26(6):477-489.
57. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. 1998. Immunologic self-tolerance maintained by CD25 + CD4 + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10(12):1969-1980. (Pubitemid 28566059)
58. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H. 2003. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170(10):4886-4890. (Pubitemid 36554716)
59. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA. 2005. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7(1):83-92.
60. Tato CM, Cua DJ. 2008. Alternative lifestyles of T cells. Nat Immunol 9(12):1323-1325.
61. Thornton AM, Shevach EM. 1998. CD4+ CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188(2):287-296. (Pubitemid 28357757)
62. Tokumasa N, Suto A, Kagami S, Furuta S, Hirose K, Watanabe N, Saito Y, Shimoda K, Iwamoto I, Nakajima H. 2007. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation. Blood 110(2):553-560. (Pubitemid 47105393)
63. Tong H, Miyazaki Y, Yamazaki M, Hara H, Waldmann H, Hori S, Yoshida H. 2010. Exacerbation of delayed-type hypersensitivity responses in EBV-induced gene-3 (EBI-3)-deficient mice. Immunol Lett 128(2):108-115.
64. Trinchieri G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133-146. (Pubitemid 37328691)
65. Tsuda M, Zhang W, Yang GX, Tsuneyama K, Ando Y, Kawata K, Park O, Leung PS, Coppel RL, Ansari AA, Ridgway WM, Gao B, Lian ZX, Flavell R, He XS, Eric Gershwin M. 2013. Deletion of IL-12p35 induces liver fibrosis in dominant negative transforming growth factor beta receptor type II mice. Hepatology. 57(2):806-816.
66. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA. 2003. The IL-27R (WSX- 1) is required to suppress T cell hyperactivity during infection. Immunity 19(5):645-655. (Pubitemid 37490790)
67. Vojdani A, Lambert J. 2011. The Role of Th17 in neuroimmune disorders: Target for CAM therapy. Part I. Evid Based Complement Alternat Med 2011:9272974.
68. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. 2011. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129(1):207-215.e5.
69. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. 2012. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol 129(1):207-215; e1-e5.
70. Wills-Karp M. 2001. IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 107(1):9-18. (Pubitemid 32105236)
71. Wirtz S, Billmeier U, McHedlidze T, Blumberg RS, Neurath MF. 2011. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141(5):1875-1886.
72. Xiao-Qing W, Helen R, Michael A. 2010. The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis. Clin Dev Immunol 2011:697340.
73. Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW. 2008. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun 76(10):4564-4573.
74. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, Sellati R, Jiang H, Zhang S, Li H, Zhao J, Ting AT, Mayer L, Unkeless JC, Labadia ME, Hodge M, Li J, Xiong H. 2008. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 38(5):1204-1214.
75. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282(13):9358-9363. (Pubitemid 47104613)
76. Yoon C, Johnston SC, Tang J, Stahl M, Tobin JF, Somers WS. 2000. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J 19(14):3530-3541. (Pubitemid 30462112)
77. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H. 2006. Two-sided roles of IL-27: Induction of Th1 differentiation on naive CD4 + T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177(8):5377-5385. (Pubitemid 44527610)
78. Zandian M, Mott K, Allen S, Dumitrascu O, Kuo J, Ghiasi H. 2011. Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2. Gene Ther 18:734-742.
79. Zhang S, Wang Q. 2008. Factors determining the formation and release of bioactive IL-12: Regulatory mechanisms for IL-12p70 synthesis and inhibition. Biochem Biophys Res Commun 372(4):509-512.
80. Zhao N. 2010. Interleukin (IL)-35 is raising our expectations. Rev Med Chil 138(6):758-766.